Seeing Is Believing
Healthcare - Sector
PHAT is currently covered by 5 analysts with an average price target of $24. This is a potential upside of $12.63 (117.19%) from yesterday's end of day stock price of $11.05.
Phathom Pharmaceuticals's activity chart (see below) currently has 74 price targets and 91 ratings on display. The stock rating distribution of PHAT is 88.89% BUY and 11.11% HOLD.
Analysts average stock forecasts to be materialized ratio is 24.17% with an average time for these price targets to be met of 84.45 days.
Highest price target for PHAT is $29, Lowest price target is $18, average price target is $24.
Most recent stock forecast was given by from HC WAINWRIGHT on 17-Jun-2026.
Currently out of the existing stock ratings of PHAT, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Aug-2023
$26
$15.28 (142.54%)
$26
29 days ago
(17-Jun-2026)
0/9 (0%)
$15 (136.36%)
Hold Since 27-Mar-2026
$18
$7.28 (67.91%)
$13
3 months 19 days ago
(27-Mar-2026)
2/3 (66.67%)
$7.42 (70.13%)
444
Buy Since 02-Feb-2021
$25
$14.28 (133.21%)
$20
4 months 19 days ago
(27-Feb-2026)
1/6 (16.67%)
$12.44 (99.04%)
134
Buy Since 07-Mar-2025
$22
$11.28 (105.22%)
$17
8 months 15 days ago
(31-Oct-2025)
1/3 (33.33%)
$8.45 (62.36%)
193
Buy Since 06-Jun-2025
$29
$18.28 (170.52%)
$29
9 months 1 days ago
(15-Oct-2025)
0/3 (0%)
$15.55 (115.61%)
What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?